Related references
Note: Only part of the references are listed.Pharmacoepidemiology research: delivering evidence about drug safety and effectiveness in mental health
Katrina A. S. Davis et al.
LANCET PSYCHIATRY (2020)
Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1)
Belinda R. Lennox et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study
Sameer Jauhar et al.
MOLECULAR PSYCHIATRY (2019)
Motivational Interviewing-Based Compliance/Adherence Therapy Interventions to Improve Psychiatric Symptoms of People With Severe Mental Illness: Meta-Analysis
Choochart Wong-Anuchit et al.
JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION (2019)
Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial
Richard I. G. Holt et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Association between increased serum D-serine and cognitive gains induced by intensive cognitive training in schizophrenia
Rogerio Panizzutti et al.
SCHIZOPHRENIA RESEARCH (2019)
Adjunctive use of anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials
Myeongju Cho et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2019)
Treatment Recommendations for Tardive Dyskinesia
Lucia Ricciardi et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2019)
Raloxifene as a treatment for cognition in women with schizophrenia: the influence of menopause status
C. Gurvich et al.
PSYCHONEUROENDOCRINOLOGY (2019)
The impact of clozapine initiation and cessation on psychiatric hospital admissions and bed days: a mirror image cohort study
D. Siskind et al.
PSYCHOPHARMACOLOGY (2019)
Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia
Jari Tiihonen et al.
JAMA PSYCHIATRY (2019)
Effects of cariprazine on hERG 1A and hERG 1A/3.1 potassium channels
Hong Joon Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Adjunctive minocycline for major mental disorders: A systematic review
Wei Zheng et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability
Jill Clayton-Smith et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Increased prevalence of ECG suspicious for Brugada Syndrome in recent onset schizophrenia spectrum disorders
Arjen L. Sutterland et al.
SCHIZOPHRENIA RESEARCH (2019)
Depressive psychopathology in first-episode schizophrenia spectrum disorders: a systematic review, meta-analysis and meta-regression
Sarah E. Herniman et al.
PSYCHOLOGICAL MEDICINE (2019)
Care of Women with Obesity in Pregnancy Green-top Guideline No. 72
F. C. Denison et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2019)
Psychopharmacological prescribing practices in pregnancy for women with severe mental illness: A multicentre study
Megan Galbally et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
Long-acting injectable second-generation antipsychotics in first-episode psychosis: a narrative review
Monika Salgueiro et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2019)
Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine
Jad Kesserwani et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trial
Mark Weiser et al.
SCHIZOPHRENIA RESEARCH (2019)
The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data
Adam Al-Diwani et al.
LANCET PSYCHIATRY (2019)
Tardive dyskinesia update: treatment and management
David Cunningham Owens
BJPSYCH ADVANCES (2019)
Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia
John M. Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2019)
British Heart Rhythm Society Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication
Pier D. Lambiase et al.
ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW (2019)
Tardive dyskinesia update: the syndrome
David Cunningham Owens
BJPSYCH ADVANCES (2019)
Clozapine rapid retitration in the community: an assertive approach can prevent admissions
Nikola Nikolic et al.
BJPSYCH ADVANCES (2019)
Pharmacokinetic Limitations on Effects of an Alpha7-Nicotinic Receptor Agonist in Schizophrenia: Randomized Trial with an Extended-Release Formulation
William R. Kem et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials
W. Zheng et al.
PSYCHOLOGICAL MEDICINE (2018)
Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies
Taishiro Kishimoto et al.
SCHIZOPHRENIA BULLETIN (2018)
Antipsychotic Combinations for Schizophrenia
Javier Ortiz-Orendain et al.
SCHIZOPHRENIA BULLETIN (2018)
Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia-A Nationwide Study With 20-Year Follow-up
Heidi Taipale et al.
SCHIZOPHRENIA BULLETIN (2018)
Capturing Rest-Activity Profiles in Schizophrenia Using Wearable and Mobile Technologies: Development, Implementation, Feasibility, and Acceptability of a Remote Monitoring Platform
Nicholas Meyer et al.
JMIR MHEALTH AND UHEALTH (2018)
Long-term antipsychotic polypharmacy prescribing in secondary mental health care and the risk of mortality
G. Kadra et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
The relationship between negative symptoms and depression in schizophrenia: a systematic review
C. R. Krynicki et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia
B. Galling et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
Mortality in schizophrenia: 30-year nationwide follow-up study
A. Tanskanen et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia
Jari Tiihonen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data
Pontus Plaven-Sigray et al.
BIOLOGICAL PSYCHIATRY (2018)
The Assessment and Treatment of Antipsychotic-Induced Akathisia
Tamara Pringsheim et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2018)
Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies
Katharina Stegmayer et al.
CNS DRUGS (2018)
Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents
Michael W. Jann et al.
CNS DRUGS (2018)
α7 Nicotinic Acetylcholine Receptor A Potential Target in Treating Cognitive Decline in Schizophrenia
Candace Jones
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2018)
Dose reduction of risperidone and olanzapine can improve cognitive function and negative symptoms in stable schizophrenic patients: A single-blinded, 52-week, randomized controlled study
Yanling Zhou et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Deep brain stimulation for tardive syndromes: Systematic review and meta analysis
Antonella Macerollo et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
The nosology of tardive syndromes
Karen Frei et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Therapeutic effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial
Zahra Sepehrmanesh et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review
Parita Shah et al.
PSYCHIATRY RESEARCH (2018)
QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update
Scott R. Beach et al.
PSYCHOSOMATICS (2018)
What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?
Christoph U. Correll et al.
WORLD PSYCHIATRY (2018)
Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis
Cathy Davies et al.
WORLD PSYCHIATRY (2018)
Anticholinergic drugs and risk of dementia: case-control study
Kathryn Richardson et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Anticholinergic drugs and risk of dementia: case-control study
Kathryn Richardson et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis
C. Okhuijsen-Pfeifer et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
Neurostimulation in tardive dystonia/dyskinesia: A delayed start, sham stimulation-controlled randomized trial
Doreen Gruber et al.
BRAIN STIMULATION (2018)
Depression during first episode psychosis and subsequent suicide risk: A systematic review and meta-analysis of longitudinal studies
Jessica McGinty et al.
SCHIZOPHRENIA RESEARCH (2018)
Correlates and predictors of antipsychotic drug polypharmacy in real-life settings: Results from a nationwide cohort study
Leo Malandain et al.
SCHIZOPHRENIA RESEARCH (2018)
Sodium valproate and clozapine induced neutropenia: A case control study using register data
Steffi Malik et al.
SCHIZOPHRENIA RESEARCH (2018)
Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review
Meghan Bowtell et al.
SCHIZOPHRENIA RESEARCH (2018)
Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia
Heidi Taipale et al.
SCHIZOPHRENIA RESEARCH (2018)
Comparing early signs and basic symptoms as methods for predicting psychotic relapse in clinical practice
Emily Eisner et al.
SCHIZOPHRENIA RESEARCH (2018)
Evaluation of adherence patterns in schizophrenia using electronic monitoring (MEMS®): A six-month post-discharge prospective study
David Misdrahi et al.
SCHIZOPHRENIA RESEARCH (2018)
Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review
Kristen N. Knoph et al.
SCHIZOPHRENIA RESEARCH (2018)
Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders
Alan Breier et al.
SCHIZOPHRENIA RESEARCH (2018)
Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis
Maren Carbon et al.
WORLD PSYCHIATRY (2018)
Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes
Yoshie Omachi et al.
FRONTIERS IN PSYCHIATRY (2018)
Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births
Shan-Yan Gao et al.
BMC MEDICINE (2018)
Cognitive improvement of acetylcholinesterase inhibitors in schizophrenia
Borja Santos et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophrenia
Sophie Hackinger et al.
TRANSLATIONAL PSYCHIATRY (2018)
Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate-Type Glutamate Receptor Function
Joshua T. Kantrowitz et al.
BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING (2018)
NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical course
B. Nelson et al.
NPJ SCHIZOPHRENIA (2018)
Evaluating the risk of QTc prolongation associated with antidepressant use in older adults: a review of the evidence
Matthew P. Rochester et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2018)
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial
Bill Deakin et al.
LANCET PSYCHIATRY (2018)
Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial
Christy L. M. Hui et al.
LANCET PSYCHIATRY (2018)
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study
Rene S. Kahn et al.
LANCET PSYCHIATRY (2018)
Mechanisms Underlying the Actions of Antidepressant and Antipsychotic Drugs That Cause Sudden Cardiac Arrest
Serge Sicouri et al.
ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW (2018)
Treatment With Antipsychotics in Pregnancy: Changes in Drug Disposition
Andreas A. Westin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis
Janna de Boer et al.
NPJ SCHIZOPHRENIA (2018)
Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials
Johannes Schneider-Thoma et al.
LANCET PSYCHIATRY (2018)
Clozapine in Reducing Aggression and Violence in Forensic Populations
Kathleen Patchan et al.
PSYCHIATRIC QUARTERLY (2018)
Negative symptoms of schizophrenia: new developments and unanswered research questions
Silvana Galderisi et al.
LANCET PSYCHIATRY (2018)
First-generation versus second-generation long-acting injectable antipsychotic drugs and time to relapse
James M. Stone et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2018)
Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia
R. McCutcheon et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
Switching and augmentation strategies for antipsychotic medications in acute-phase schizophrenia: latest evidence and place in therapy
Kotaro Hatta et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2018)
Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial
Thomas R. E. Barnes et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2018)
The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses
Peter M. Haddad et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2018)
Relapse After Antipsychotic Discontinuation in Schizophrenia as a Withdrawal Phenomenon vs Illness Recurrence: A Post Hoc Analysis of a Randomized Placebo-Controlled Study
Robin Emsley et al.
JOURNAL OF CLINICAL PSYCHIATRY (2018)
Maintenance antipsychotic treatment versus discontinuation strategies following remission from first episode psychosis: systematic review
Andrew Thompson et al.
BJPSYCH OPEN (2018)
Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study
Anthony P. Morrison et al.
LANCET PSYCHIATRY (2018)
Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies
Zi-Qi Shen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Pharmacokinetics and Pharmacodynamics of Lurasidone Hydrochloride, a Second-Generation Antipsychotic: A Systematic Review of the Published Literature
William M. Greenberg et al.
CLINICAL PHARMACOKINETICS (2017)
D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity
Donald C. Goff
CURRENT NEUROPHARMACOLOGY (2017)
Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review
John Yin et al.
CURRENT NEUROPHARMACOLOGY (2017)
Evidence for the hERG Liability of Antihistamines, Antipsychotics, and Anti-Infective Agents: A Systematic Literature Review From the ARITMO Project
Lorna Hazell et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions
Brian J. Miller et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study
Andreas Schreiner et al.
PSYCHOPHARMACOLOGY (2017)
Bipolar At-Risk Criteria: An Examination of Which Clinical Features Have Optimal Utility for Identifying Youth at Risk of Early Transition From Depression to Bipolar Disorders
Jan Scott et al.
SCHIZOPHRENIA BULLETIN (2017)
Risk factors for QTc-prolongation: systematic review of the evidence
Eline Vandael et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2017)
Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials
Ying-Qiang Xiang et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
How well do patients with a first episode of schizophrenia respond to antipsychotics: A systematic review and meta-analysis
Yikang Zhu et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia
Hanna Bergman et al.
HEALTH TECHNOLOGY ASSESSMENT (2017)
Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial
Mark Weiser et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials
Wei Zheng et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis
Maren Carbon et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
High Incidence and Prevalence of Drug-Related Movement Disorders in Young Patients With Psychotic Disorders
Thierry Q. Mentzel et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia
Robert W. Buchanan et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials
Wei Zheng et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288
Kelvin W. Gee et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment
Gavin P. Reynolds et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017
R. Hamish McAllister-Williams et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
The 2016 Royal Australian and New Zealand College of Psychiatrists guidelines for the management of schizophrenia and related disorders
David J. Castle et al.
MEDICAL JOURNAL OF AUSTRALIA (2017)
Cognition and the Course of Prodromal Parkinson's Disease
Daniel Weintraub et al.
MOVEMENT DISORDERS (2017)
Randomized controlled trial of deutetrabenazine for tardive dyskinesia The ARM-TD study
Hubert H. Fernandez et al.
NEUROLOGY (2017)
Violence to Others, Violent Self-Victimization, and Violent Victimization by Others Among Persons With a Mental Illness
John Monahan et al.
PSYCHIATRIC SERVICES (2017)
The critical treatment window of clozapine in treatment-resistant schizophrenia: Secondary analysis of an observational study
Bunta Yoshimura et al.
PSYCHIATRY RESEARCH (2017)
Stability and development of psychotic symptoms and the use of antipsychotic medication - long-term follow-up
D. R. Gotfredsen et al.
PSYCHOLOGICAL MEDICINE (2017)
Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
A. Demjaha et al.
PSYCHOLOGICAL MEDICINE (2017)
Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis
J. Vermeulen et al.
PSYCHOLOGICAL MEDICINE (2017)
Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis
Taro Kishi et al.
PSYCHOPHARMACOLOGY (2017)
Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
Guy Chouinard et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2017)
112. Effects of Ziprasidone Versus Placebo in Patients at Clinical High Risk for Psychosis
Scott Woods et al.
SCHIZOPHRENIA BULLETIN (2017)
108. PREVENT: A Randomized Controlled Trial for the Prevention of First-Episode Psychosis Comparing Cognitive–Behavior Therapy (CBT), Clinical Management, and Aripiprazole Combined and Clinical Management and Placebo Combined
Andreas Bechdolf et al.
SCHIZOPHRENIA BULLETIN (2017)
23. Omega-3 Fatty Acid Versus Placebo in a Clinical High-Risk Sample From the North American Prodrome Longitudinal Studies (NAPLS) Consortium
Kristin Cadenhead et al.
SCHIZOPHRENIA BULLETIN (2017)
Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis
Britta Galling et al.
WORLD PSYCHIATRY (2017)
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls
Christoph U. Correll et al.
WORLD PSYCHIATRY (2017)
Increased postpartum haemorrhage, the possible relation with serotonergic and other psychopharmacological drugs: a matched cohort study
Hanna M. Heller et al.
BMC PREGNANCY AND CHILDBIRTH (2017)
Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis
Areti Angeliki Veroniki et al.
BMJ OPEN (2017)
Statin prescribing for people with severe mental illnesses: a staggered cohort study of 'real-world' impacts
R. Blackburn et al.
BMJ OPEN (2017)
Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia Systematic Overview and Quality Appraisal of the Meta-analytic Evidence
Christoph U. Correll et al.
JAMA PSYCHIATRY (2017)
Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia
Jari Tiihonen et al.
JAMA PSYCHIATRY (2017)
Impaired Glucose Homeostasis in First-Episode Schizophrenia A Systematic Review and Meta-analysis
Toby Pillinger et al.
JAMA PSYCHIATRY (2017)
Effect of omega-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders The NEURAPRO Randomized Clinical Trial
Patrick D. McGorry et al.
JAMA PSYCHIATRY (2017)
Raloxifene Improves Cognition in Schizophrenia: Spurious Result or Valid Effect?
Thomas W. Weickert et al.
FRONTIERS IN PSYCHIATRY (2017)
Switching away from pipotiazine palmitate: a naturalistic study
Feras Ali Mustafa
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2017)
Treatment of depression in schizophrenia: systematic review and meta-analysis
Atigharad Gregoigi et al.
BRITISH JOURNAL OF PSYCHIATRY (2017)
Mortality and Self-Harm in Association With Clozapine in Treatment-Resistant Schizophrenia
Theresa Wimberley et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Are Depot Anti-psychotics Associated with Longer Persistence in Treatment Compared with Oral Antipsychotics among Patients with Schizophrenia?
Increase Ibukun Adeosun
BRITISH JOURNAL OF PHARMACEUTICAL RESEARCH (2017)
Clozapine Response Rates among People with Treatment-Resistant Schizophrenia: Data from a Systematic Review and Meta-Analysis
Dan Siskind et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2017)
Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors
Stefan Leucht et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Clinical utility of magnetic resonance imaging in first-episode psychosis
Irina Falkenberg et al.
BRITISH JOURNAL OF PSYCHIATRY (2017)
One-year symptom trajectories in patients with stable schizophrenia maintained on antipsychotics versus placebo: meta-analysist
Hiroyoshi Takeuchi et al.
BRITISH JOURNAL OF PSYCHIATRY (2017)
Guidelines for the Pharmacotherapy of Schizophrenia in Adults
Gary Remington et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2017)
Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014
Joseph F. Hayes et al.
BRITISH JOURNAL OF PSYCHIATRY (2017)
The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia
Donald C. Goff et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Association of schizophrenia onset age and white matter integrity with treatment effect of D-cycloserine: a randomized placebo-controlled double-blind crossover study
Kazuo Takiguchi et al.
BMC PSYCHIATRY (2017)
Ethnicity and long-term course and outcome of psychotic disorders in a UK sample: the AESOP-10 study
Craig Morgan et al.
BRITISH JOURNAL OF PSYCHIATRY (2017)
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial
Karen E. Anderson et al.
LANCET PSYCHIATRY (2017)
Cannabis use and symptom severity in individuals at ultra high risk for psychosis: a meta-analysis
R. Carney et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte Studies
Dragana Bugarski-Kirola et al.
BIOLOGICAL PSYCHIATRY (2017)
Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population
Taro Kishi et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2017)
A systematic review of sex and age factors in neuroleptic malignant syndrome diagnosis frequency
Ronald J. Gurrera
ACTA PSYCHIATRICA SCANDINAVICA (2017)
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia
Robert A. Hauser et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
The impact of clozapine on hospital use: a systematic review and meta-analysis
R. Land et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis
Carsten Hjorthoj et al.
LANCET PSYCHIATRY (2017)
Randomized Trial of an Integrated Behavioral Health Home: The Health Outcomes Management and Evaluation (HOME) Study
Benjamin G. Druss et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review
Amy L. Gillespie et al.
BMC PSYCHIATRY (2017)
Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review
M. De Hert et al.
ACTA PSYCHIATRICA SCANDINAVICA (2016)
Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A review
Denise Froes Brandao et al.
CANCER (2016)
Sudden Cardiac and Sudden Unexpected Death Related to Antipsychotics: A Meta-analysis of Observational Studies
F. Salvo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Clinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-Episode Nonaffective Psychosis Individuals: A 3-Year Naturalistic Follow-Up Study
Jacqueline Mayoral-van Son et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis
Neal R. Swerdlow et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms
Sonia Dollfus et al.
SCHIZOPHRENIA BULLETIN (2016)
Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia
David Walling et al.
SCHIZOPHRENIA BULLETIN (2016)
Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study
Nanna Gilliam Toftdahl et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2016)
Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis
Emmert Roberts et al.
ADDICTION (2016)
Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis
Qi Wu et al.
ADDICTION (2016)
Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study
Jari Tiihonen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis
Bartosz Helfer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
A Randomized Trial to Assess the Efficacy and Safety of ABT-126, a Selective α7 Nicotinic Acetylcholine Receptor Agonist, in the Treatment of Cognitive Impairment in Schizophrenia
George M. Haig et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Neuroleptic Malignant Syndrome: Focus on Treatment and Rechallenge
Dominic J. Pileggi et al.
ANNALS OF PHARMACOTHERAPY (2016)
Is adherence therapy an effective adjunct treatment for patients with schizophrenia spectrum disorders? A systematic review and meta-analysis
Richard Gray et al.
BMC PSYCHIATRY (2016)
Clozapine V. first-and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis
Dan Siskind et al.
BRITISH JOURNAL OF PSYCHIATRY (2016)
Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era
M. Alvarez-Jimenez et al.
CNS DRUGS (2016)
Worldwide Differences in Regulations of Clozapine Use
Jimmi Nielsen et al.
CNS DRUGS (2016)
Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia
Eduard Parellada et al.
CNS DRUGS (2016)
Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital
Keir Stone-Brown et al.
CNS SPECTRUMS (2016)
Antipsychotic Management of Schizoaffective Disorder: A Review
Jean-Pierre Lindenmayer et al.
DRUGS (2016)
Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review
Marc De Hert et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records
Irene Petersen et al.
HEALTH TECHNOLOGY ASSESSMENT (2016)
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
Thomas R. E. Barnes et al.
HEALTH TECHNOLOGY ASSESSMENT (2016)
Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy
Larry Alphs et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2016)
Antipsychotic polypharmacy and quality of life in patients with schizophrenia treated in primary care in China
Cai-Lan Hou et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2016)
Sudden-Onset Catatonia Following Clozapine Withdrawal: A Case Report
Ivan Koychev et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based Real-World Study
Chen Zhang et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence
Christoph U. Correll et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Second-Generation Antipsychotics During the Lactation Period A Comparative Systematic Review on Infant Safety
Faruk Uguz
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives
Jaya L. Padmanabhan et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2016)
Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders
Joseph V. Thompson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up
Hiroshi Kimura et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Neuroscience-based Nomenclature (NbN) for Journal of Psychopharmacology
David J. Nutt et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
G. M. Goodwin et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment
Stephen J. Cooper et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
Robert M. Anthenelli et al.
LANCET (2016)
Significant Effect of Valproate Augmentation Therapy in Patients With Schizophrenia A Meta-analysis Study
Ping-Tao Tseng et al.
MEDICINE (2016)
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
D. R. Goldsmith et al.
MOLECULAR PSYCHIATRY (2016)
Postpartum Hemorrhage and Use of Serotonin Reuptake Inhibitor Antidepressants in Pregnancy
Gillian E. Hanley et al.
OBSTETRICS AND GYNECOLOGY (2016)
Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial
Robert C. Smith et al.
PLOS ONE (2016)
Task-related fMRI responses to a nicotinic acetylcholine receptor partial agonist in schizophrenia: A randomized trial
Deanna M. Barch et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Long-acting injectable antipsychotics for the prevention of relapse in patients with recent-onset psychotic disorders: A systematic review and meta-analysis of randomized controlled trials
Taro Kishi et al.
PSYCHIATRY RESEARCH (2016)
Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses
J. Lally et al.
PSYCHOLOGICAL MEDICINE (2016)
Effects of acute memantine administration on MATRICS Consensus Cognitive Battery performance in psychosis: Testing an experimental medicine strategy
Savita G. Bhakta et al.
PSYCHOPHARMACOLOGY (2016)
A Meta-analytic Review of Auditory Event-Related Potential Components as Endophenotypes for Schizophrenia: Perspectives From First-Degree Relatives
Holly A. Earls et al.
SCHIZOPHRENIA BULLETIN (2016)
Reasons for discontinuing clozapine: A cohort study of patients commencing treatment
Sophie E. Legge et al.
SCHIZOPHRENIA RESEARCH (2016)
Cardiometabolic risk factors in young people at ultra-high risk for psychosis: A systematic review and meta-analysis
Rebekah Carney et al.
SCHIZOPHRENIA RESEARCH (2016)
Predictors of long-term (≥ 6 months) antipsychotic polypharmacy prescribing in secondary mental healthcare
Giouliana Kadra et al.
SCHIZOPHRENIA RESEARCH (2016)
Declining transition rates to psychotic disorder in ultra-high risk clients: Investigation of a dilution effect
Jessica A. Hartmann et al.
SCHIZOPHRENIA RESEARCH (2016)
The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesity
Helene Speyer et al.
WORLD PSYCHIATRY (2016)
Discontinuing financial incentives for adherence to antipsychotic depot medication: long-term outcomes of a cluster randomised controlled trial
Stefan Priebe et al.
BMJ OPEN (2016)
Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women A Randomized Clinical Trial
Jayashri Kulkarni et al.
JAMA PSYCHIATRY (2016)
Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia A Network Meta-analysis
Myrto T. Samara et al.
JAMA PSYCHIATRY (2016)
Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations
Krista F. Huybrechts et al.
JAMA PSYCHIATRY (2016)
Amisulpride Switching in Schizophrenic Patients Who Showed Suboptimal Effect and/or Tolerability to Current Antipsychotics in a Naturalistic Setting: An Explorative Study
Yongmin Kim et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2016)
Combining depot antipsychotic with an assertive monitoring programme for treating first-episode schizophrenia in a resource-constrained setting
Bonginkosi Chiliza et al.
EARLY INTERVENTION IN PSYCHIATRY (2016)
Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias
Luigi X. Cubeddu
CURRENT CARDIOLOGY REVIEWS (2016)
Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review
Craig Karson et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2016)
The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis
Benjamin Ian Perry et al.
LANCET PSYCHIATRY (2016)
Second-generation antipsychotic effect on cognition in patients with schizophrenia-a meta-analysis of randomized clinical trials
R. E. Nielsen et al.
ACTA PSYCHIATRICA SCANDINAVICA (2015)
Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review
Myrto T. Samara et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Outcomes of Nontransitioned Cases in a Sample at Ultra-High Risk for Psychosis
Ashleigh Lin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Pregnancy Exposure to Olanzapine, Quetiapine, Risperidone, Aripiprazole and Risk of Congenital Malformations. A Systematic Review
Zandra Nymand Ennis et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2015)
The characteristics and health needs of pregnant women with schizophrenia compared with bipolar disorder and affective psychoses
Clare L. Taylor et al.
BMC PSYCHIATRY (2015)
Duration of untreated psychosis and need for admission in patients who engage with mental health services in the prodromal phase
Lucia R. Valmaggia et al.
BRITISH JOURNAL OF PSYCHIATRY (2015)
The Therapeutic Potential of α7 Nicotinic Acetylcholine Receptor (α7 nAChR) Agonists for the Treatment of the Cognitive Deficits Associated with Schizophrenia
Corinne Beinat et al.
CNS DRUGS (2015)
The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics
Marc De Hert et al.
CNS DRUGS (2015)
Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective
Lurdes Tse et al.
CURRENT NEUROPHARMACOLOGY (2015)
Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study
Benjamin Sneider et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies
Pal Czobor et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Suicidal behaviour in first-episode non-affective psychosis: Specific risk periods and stage-related factors
Rosa Ayesa-Arriola et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database
Erica A. Voss et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2015)
Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis
Xinyu Zhou et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Antidepressant Use Late in Pregnancy and Risk of Persistent Pulmonary Hypertension of the Newborn
Krista F. Huybrechts et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Optimizing Outcomes in Clozapine Rechallenge Following Neutropenia: A Cohort Analysis
Nicholas Meyer et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Importance of Early Weight Changes to Predict Long-Term Weight Gain During Psychotropic Drug Treatment
Frederik Vandenberghe et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia
Somaia Mohamed et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2015)
Treatment resistant or resistant to treatment? Antipsychotic plasma levels in patients with poorly controlled psychotic symptoms
Robert McCutcheon et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
Anthony Cleare et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia
T. W. Weickert et al.
MOLECULAR PSYCHIATRY (2015)
Parkinsonism following neuroleptic exposure: A double-hit hypothesis?
Roberto Erro et al.
MOVEMENT DISORDERS (2015)
Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia
Richard S. E. Keefe et al.
NEUROPSYCHOPHARMACOLOGY (2015)
A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders
Kyra-Verena Sendt et al.
PSYCHIATRY RESEARCH (2015)
Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial
P. Gardner-Sood et al.
PSYCHOLOGICAL MEDICINE (2015)
Endophenotypes in Schizophrenia for the Perinatal Period: Criteria for Validation
Randal G. Ross et al.
SCHIZOPHRENIA BULLETIN (2015)
Modeling Determinants of Medication Attitudes and Poor Adherence in Early Nonaffective Psychosis: Implications for Intervention
Richard J. Drake et al.
SCHIZOPHRENIA BULLETIN (2015)
Magnetic Resonance Imaging and the Prediction of Outcome in First-Episode Schizophrenia: A Review of Current Evidence and Directions for Future Research
Paola Dazzan et al.
SCHIZOPHRENIA BULLETIN (2015)
Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders
Suraj Sarvode Mothi et al.
SCHIZOPHRENIA RESEARCH (2015)
tDose escalation of antipsychotic drugs in schizophrenia: A meta-analysis of randomized controlled trials
Markus Dold et al.
SCHIZOPHRENIA RESEARCH (2015)
Glasgow Antipsychotic Side-effects Scale for Clozapine - Development and validation of a clozapine-specific side-effects scale
Caroline Hynes et al.
SCHIZOPHRENIA RESEARCH (2015)
Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis
Lawrence H. Yang et al.
SCHIZOPHRENIA RESEARCH (2015)
Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia
Andreas Schreiner et al.
SCHIZOPHRENIA RESEARCH (2015)
Sex hormones and oxytocin augmentation strategies in schizophrenia: A quantitative review
Sophie M. Heringa et al.
SCHIZOPHRENIA RESEARCH (2015)
Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis
Martino Belvederi Murri et al.
DRUGS IN R&D (2015)
Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study
G. Paul Amminger et al.
NATURE COMMUNICATIONS (2015)
Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response-a prospective open-label study
Naoki Hashimoto et al.
ANNALS OF GENERAL PSYCHIATRY (2015)
Screening for the metabolic side effects of antipsychotic medication: findings of a 6-year quality improvement programme in the UK
T. R. E. Barnes et al.
BMJ OPEN (2015)
Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis
Kyla H. Thomas et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study
Simone N. Vigod et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis
Kyla H. Thomas et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study
Simone N. Vigod et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Antipsychotic Drugs and the Risk of Ventricular Arrhythmia and/or Sudden Cardiac Death: A Nation-wide Case-Crossover Study
Chi-Shin Wu et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Cumulative Use of Strong Anticholinergics and Incident Dementia A Prospective Cohort Study
Shelly L. Gray et al.
JAMA INTERNAL MEDICINE (2015)
Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia A Randomized Clinical Trial
Kenneth L. Subotnik et al.
JAMA PSYCHIATRY (2015)
Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia A Randomized Clinical Trial
Joris Berwaerts et al.
JAMA PSYCHIATRY (2015)
Stimulant use disorders in people with psychosis: A meta-analysis of rate and factors affecting variation
Grant E. Sara et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2015)
What needs to follow early intervention? Predictors of relapse and functional recovery following first-episode psychosis
Shi Mei Kam et al.
EARLY INTERVENTION IN PSYCHIATRY (2015)
Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study
Ruth Brauer et al.
EUROPEAN HEART JOURNAL (2015)
Paliperidone Palmitate Once-Monthly Reduces Risk of Relapse of Psychotic, Depressive, and Manic Symptoms and Maintains Functioning in a Double-Blind, Randomized Study of Schizoaffective Disorder
Dong-Jing Fu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Diabetes mellitus and severe mental illness: mechanisms and clinical implications
Richard I. G. Holt et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Congenital Anomalies in Children of Mothers Taking Antiepileptic Drugs with and without Periconceptional High Dose Folic Acid Use: A Population-Based Cohort Study
Lu Ban et al.
PLOS ONE (2015)
Antipsychotic Treatment and Mortality in Schizophrenia
Minna Torniainen et al.
SCHIZOPHRENIA BULLETIN (2015)
The Kraepelinian Dichotomy Viewed by Neuroimaging
Marc-Antoine d'Albis et al.
SCHIZOPHRENIA BULLETIN (2015)
Comparative Effectiveness of Risperidone Long-Acting Injectable vs First-Generation Antipsychotic Long-Acting Injectables in Schizophrenia: Results From a Nationwide, Retrospective Inception Cohort Study
Jimmi Nielsen et al.
SCHIZOPHRENIA BULLETIN (2015)
Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
Paolo Fusar-Poli et al.
SCHIZOPHRENIA BULLETIN (2015)
Pharmacotherapy of cognition in schizophrenia
Herbert Y. Meltzer
CURRENT OPINION IN BEHAVIORAL SCIENCES (2015)
Paliperidone Palmitate for Schizoaffective Disorder: A Review of the Clinical Evidence
William M. Greenberg et al.
NEUROLOGY AND THERAPY (2015)
Pharmacologic approaches to treatment resistant depression: Evidences and personal experience
Antonio Tundo et al.
WORLD JOURNAL OF PSYCHIATRY (2015)
Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies
R. Douglas Wilson et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2015)
D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial
Joshua T. Kantrowitz et al.
LANCET PSYCHIATRY (2015)
Practitioner attitudes to clozapine initiation
S. Gee et al.
ACTA PSYCHIATRICA SCANDINAVICA (2014)
The practical management of refractory schizophrenia - the Maudsley Treatment REview and Assessment Team service approach
K. Beck et al.
ACTA PSYCHIATRICA SCANDINAVICA (2014)
alpha 7-Nicotinic Acetylcholine Receptor Agonists for Cognitive Enhancement in Schizophrenia
Robert Freedman
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
Maternal and newborn outcomes among women with schizophrenia: a retrospective population-based cohort study
S. N. Vigod et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2014)
A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection
Susan Atkins et al.
BMC PSYCHIATRY (2014)
Assessment and treatment of physical health problems among people with schizophrenia: national cross-sectional study
Mike J. Crawford et al.
BRITISH JOURNAL OF PSYCHIATRY (2014)
Brugada Syndrome ECG Is Highly Prevalent in Schizophrenia
Marieke T. Blom et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2014)
Differentiating Drug-Induced Multichannel Block on the Electrocardiogram: Randomized Study of Dofetilide, Quinidine, Ranolazine, and Verapamil
L. Johannesen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study
Jan Volavka et al.
CNS SPECTRUMS (2014)
Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital
James E. Hotham et al.
CNS SPECTRUMS (2014)
The psychopharmacology of violence: making sensible decisions
Leslie Citrome et al.
CNS SPECTRUMS (2014)
Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: A comparison of methods for the measurement of adherence in schizophrenia
Cecilia Brain et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Effects of raloxifene on cognition in postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial
Elena Huerta-Ramos et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
How antipsychotics impact the different dimensions of Schizophrenia: A test of competing hypotheses
Tiago Reis Marques et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Improved quality of life over one year is associated with improved adherence in patients with schizophrenia
K. P. Hayhurst et al.
EUROPEAN PSYCHIATRY (2014)
Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature review
Marc De Hert et al.
EXPERT OPINION ON DRUG SAFETY (2014)
Structural neuroimaging in psychosis: a systematic review and economic evaluation
E Albon et al.
HEALTH TECHNOLOGY ASSESSMENT (2014)
Critical review of antipsychotic polypharmacy in the treatment of schizophrenia
W. Wolfgang Fleischhacker et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia A Randomized Clinical Trial
Joseph P. McEvoy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Pharmacological Management of Persistent Hostility and Aggression in Persons With Schizophrenia Spectrum Disorders: A Systematic Review
Jeff Victoroff et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2014)
Normalizing Effects of EVP-6124, an Alpha-7 Nicotinic Partial Agonist, on Event-Related Potentials and Cognition: A Proof of Concept, Randomized Trial in Patients with Schizophrenia
Sheldon H. Preskorn et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2014)
Family-Focused Treatment for Adolescents and Young Adults at High Risk for Psychosis: Results of a Randomized Trial
David J. Miklowitz et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2014)
Antipsychotics, mood stabilisers, and risk of violent crime
Seena Fazel et al.
LANCET (2014)
Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial
Anthony P. Morrison et al.
LANCET (2014)
A Randomized, Placebo-Controlled Study Investigating the Nicotinic α7 Agonist, RG3487, for Cognitive Deficits in Schizophrenia
Daniel Umbricht et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Inflammation and the two-hit hypothesis of schizophrenia
Keith A. Feigenson et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
Mortality, attempted suicide, re-hospitalisation and prescription refill for clozapine and other antipsychotics in Sweden-a register-based study
Gunilla Ringback Weitoft et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)
Clozapine Augmented with Glutamate Modulators in Refractory Schizophrenia: A Review and Metaanalysis
S. R. T. Veerman et al.
PHARMACOPSYCHIATRY (2014)
Special Section on Implications of CATIE: Lessons to Take Home From CATIE
William T. Carpenter et al.
PSYCHIATRIC SERVICES (2014)
Time to Discontinuation of Depot and Oral First-Generation Antipsychotics in the Usual Care of Schizophrenia
Baojin Zhu et al.
PSYCHIATRIC SERVICES (2014)
Medication Preferences and Adherence Among Individuals With Severe Mental Illness and Psychiatric Advance Directives
Christine M. Wilder et al.
PSYCHIATRIC SERVICES (2014)
Depression in first episode psychosis: The role of subordination and shame
Rachel Upthegrove et al.
PSYCHIATRY RESEARCH (2014)
Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study
M. Harrow et al.
PSYCHOLOGICAL MEDICINE (2014)
Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study
C. Morgan et al.
PSYCHOLOGICAL MEDICINE (2014)
Comorbid Depressive and Anxiety Disorders in 509 Individuals With an At-Risk Mental State: Impact on Psychopathology and Transition to Psychosis
Paolo Fusar-Poli et al.
SCHIZOPHRENIA BULLETIN (2014)
Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
Iris E. Sommer et al.
SCHIZOPHRENIA BULLETIN (2014)
Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method
Stefan Leucht et al.
SCHIZOPHRENIA BULLETIN (2014)
D-Cycloserine augmentation of cognitive remediation in schizophrenia
Christopher K. Cain et al.
SCHIZOPHRENIA RESEARCH (2014)
Risk of symptom recurrence with medication discontinuation in first-episode psychosis: A systematic review
Robert B. Zipursky et al.
SCHIZOPHRENIA RESEARCH (2014)
Rates and predictors of remission in first-episode schizophrenia within 1 year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia
Wolfgang Gaebel et al.
SCHIZOPHRENIA RESEARCH (2014)
Impact of early intervention services on duration of untreated psychosis: Data from the National EDEN prospective cohort study
Max Marshall et al.
SCHIZOPHRENIA RESEARCH (2014)
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study
Michele Tinazzi et al.
SCHIZOPHRENIA RESEARCH (2014)
Antipsychotic Drugs and Safety Concerns for Breast-Feeding Infants
Tapan Parikh et al.
SOUTHERN MEDICAL JOURNAL (2014)
Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders Baseline Results From the RAISE-ETP Study
Christoph U. Correll et al.
JAMA PSYCHIATRY (2014)
Multimodal assessments of the hippocampal formation in schizophrenia and bipolar disorder: Evidences from neurobehavioral measures and functional and structural MRI
Christian Knoechel et al.
NEUROIMAGE-CLINICAL (2014)
Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions
Petter Andreas Ringen et al.
FRONTIERS IN PSYCHIATRY (2014)
Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies
Peter M. Haddad et al.
PATIENT-RELATED OUTCOME MEASURES (2014)
Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approach
Matisyahu Shulman et al.
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE (2014)
Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis
T. A. Pollak et al.
PSYCHOLOGICAL MEDICINE (2014)
Profile of minocycline and its potential in the treatment of schizophrenia
Lulu Zhang et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: A randomized study
Thomas Schnell et al.
AMERICAN JOURNAL ON ADDICTIONS (2014)
Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective
Markus Dold et al.
EVIDENCE-BASED MENTAL HEALTH (2014)
Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study
Francois R. Girardin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Comorbidities and Mortality in Persons With Schizophrenia: A Swedish National Cohort Study
Casey Crump et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
The Clinical Assessment Interview for Negative Symptoms (CAINS): Final Development and Validation
Ann M. Kring et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Statins and Cognitive Function
Karl Richardson et al.
ANNALS OF INTERNAL MEDICINE (2013)
A Comparison of the Risk of QT Prolongation Among SSRIs
Kylee A. Funk et al.
ANNALS OF PHARMACOTHERAPY (2013)
Should long-acting (depot) antipsychotics be used in early schizophrenia? A systematic review
Mark Taylor et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013)
Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)
Deanna L. Kelly et al.
BMC PSYCHIATRY (2013)
Effect of prior treatment with antipsychotic long-acting injection on randomised clinical trial treatment outcomes
Thomas R. E. Barnes et al.
BRITISH JOURNAL OF PSYCHIATRY (2013)
Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value
Jan Scott et al.
BRITISH JOURNAL OF PSYCHIATRY (2013)
Cognitive function in schizophrenia: insights from intelligence research
Eileen M. Joyce
BRITISH JOURNAL OF PSYCHIATRY (2013)
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study
Mehdi Farokhnia et al.
CLINICAL NEUROPHARMACOLOGY (2013)
Efficacy of olanzapine in comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic review and meta-analyses
Juliano S. Souza et al.
CNS SPECTRUMS (2013)
Polypharmacy for schizophrenia
Jacob Ballon et al.
CURRENT OPINION IN PSYCHIATRY (2013)
Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged <18years: data from a therapeutic drug monitoring service, 1994-2010
Lewis Couchman et al.
EARLY INTERVENTION IN PSYCHIATRY (2013)
Antipsychotic response in first-episode schizophrenia: efficacy of high doses and switching
Ofer Agid et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Effect of lurasidone on neurocognitive performance in patients with schizophrenia: A short-term placebo- and active-controlled study followed by a 6-month double-blind extension
Philip D. Harvey et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS®) in the Swedish COAST-study
Cecilia Brain et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Outreach and support in South London (OASIS), 2001-2011: Ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis
P. Fusar-Poli et al.
EUROPEAN PSYCHIATRY (2013)
New second-generation long-acting injectable antipsychotics for the treatment of schizophrenia
Leslie Citrome
EXPERT REVIEW OF NEUROTHERAPEUTICS (2013)
Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis
Jian-Ping Zhang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
Jakob Christensen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
The subjective experience and phenomenology of depression following first episode psychosis: A qualitative study using photo-elicitation
Amrita Sandhu et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Twelve-Month Outcome
Patrick D. McGorry et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Efficacy and Effectiveness of Depot Versus Oral Antipsychotics in Schizophrenia: Synthesizing Results Across Different Research Designs
Noam Y. Kirson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Termination of Clozapine Treatment Due to Medical Reasons: When Is It Warranted and How Can It Be Avoided?
Jimmi Nielsen et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Atypical Antipsychotic Drugs and Pregnancy Outcome A Prospective, Cohort Study
Frank Habermann et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Comparison of Treatment Response in Second-Episode Versus First-Episode Schizophrenia
Robin Emsley et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Stefan Leucht et al.
LANCET (2013)
Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: A proof-of-mechanism study
Georg Winterer et al.
NEUROPHARMACOLOGY (2013)
A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia
Jeffrey A. Lieberman et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Feasibility, Safety, and Efficacy of the Combination of D-Serine and Computerized Cognitive Retraining in Schizophrenia: An International Collaborative Pilot Study
Deepak C. D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Acute and subacute drug-induced movement disorders
Pierre R. Burkhard
PARKINSONISM & RELATED DISORDERS (2013)
Adjunctive Aripiprazole Versus Placebo for Antipsychotic-Induced Hyperprolactinemia: Meta-Analysis of Randomized Controlled Trials
Xianbin Li et al.
PLOS ONE (2013)
Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study
Mei Peng et al.
PSYCHOPHARMACOLOGY (2013)
Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders-A Systematic Review and Meta-Analysis
Alex J. Mitchell et al.
SCHIZOPHRENIA BULLETIN (2013)
How Frequent Are Radiological Abnormalities in Patients With Psychosis? A Review of 1379 MRI Scans
Iris E. Sommer et al.
SCHIZOPHRENIA BULLETIN (2013)
Intermittent Drug Techniques for Schizophrenia
Stephanie Sampson et al.
SCHIZOPHRENIA BULLETIN (2013)
The Effect of Motivational Interviewing on Medication Adherence and Hospitalization Rates in Nonadherent Patients with Multi-Episode Schizophrenia
Emile Barkhof et al.
SCHIZOPHRENIA BULLETIN (2013)
Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
Stephen R. Marder et al.
SCHIZOPHRENIA RESEARCH (2013)
Randomized trial of clozapine vs. risperidone in treatment-naive first-episode schizophrenia: Results after one year
Javier Sanz-Fuentenebro et al.
SCHIZOPHRENIA RESEARCH (2013)
How to compare doses of different antipsychotics: A systematic review of methods
Maxine X. Patel et al.
SCHIZOPHRENIA RESEARCH (2013)
Antipsychotics and mortality in first-onset schizophrenia: Prospective Finnish register study with 5-year follow-up
Marjo Kiviniemi et al.
SCHIZOPHRENIA RESEARCH (2013)
Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment
Sefa Vayisoglu et al.
SCHIZOPHRENIA RESEARCH (2013)
Preventing a first episode of psychosis: Meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups
Mark van der Gaag et al.
SCHIZOPHRENIA RESEARCH (2013)
Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades - A Danish nationwide study from 1980 to 2010
Rene Ernst Nielsen et al.
SCHIZOPHRENIA RESEARCH (2013)
A meta-analysis of cardio-metabolic abnormalities in drug naive, first-episode and multi-episode patients with schizophrenia versus general population controls
Davy Vancampfort et al.
WORLD PSYCHIATRY (2013)
Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies
John M. Kane et al.
WORLD PSYCHIATRY (2013)
Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis
Goran Medic et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2013)
Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review
Jose M. Olivares et al.
ANNALS OF GENERAL PSYCHIATRY (2013)
Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: cross-sectional study
Daniel J. Smith et al.
BMJ OPEN (2013)
Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States
Kristin Palmsten et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial
Stefan Priebe et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers
David Lawrence et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Boundaries of Schizoaffective Disorder Revisiting Kraepelin
Roman Kotov et al.
JAMA PSYCHIATRY (2013)
The Psychosis High-Risk State A Comprehensive State-of-the-Art Review
Paolo Fusar-Poli et al.
JAMA PSYCHIATRY (2013)
Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy Long-term Follow-up of a 2-Year Randomized Clinical Trial
Lex Wunderink et al.
JAMA PSYCHIATRY (2013)
Pathways to Violent Behavior During First-Episode Psychosis A Report From the UK National EDEN Study
Catherine Winsper et al.
JAMA PSYCHIATRY (2013)
Comparative Mortality Risk in Adult Patients With Schizophrenia, Depression, Bipolar Disorder, Anxiety Disorders, and Attention-Deficit/Hyperactivity Disorder Participating in Psychopharmacology Clinical Trials
Arif Khan et al.
JAMA PSYCHIATRY (2013)
Selected Pregnancy and Delivery Outcomes After Exposure to Antidepressant Medication A Systematic Review and Meta-analysis
Lori E. Ross et al.
JAMA PSYCHIATRY (2013)
Long-term remission in schizophrenia and schizoaffective disorder: results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)
Enrico Smeraldi et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2013)
Assessing early signs of relapse in psychosis: Review and future directions
Emily Eisner et al.
CLINICAL PSYCHOLOGY REVIEW (2013)
Augmentation of clozapine with a second antipsychotic - a meta-analysis
D. M. Taylor et al.
ACTA PSYCHIATRICA SCANDINAVICA (2012)
Citalopram, QTc Interval Prolongation, and Torsade de Pointes. How Should We Apply the Recent FDA Ruling?
W. Victor R. Vieweg et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Short-Term Tropisetron Treatment and Cognitive and P50 Auditory Gating Deficits in Schizophrenia
Xiang Yang Zhang et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
Arsime Demjaha et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Polypharmacy With Antipsychotics, Antidepressants, or Benzodiazepines and Mortality in Schizophrenia
Jari Tiihonen et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Predicting Psychosis Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk
Paolo Fusar-Poli et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
Oliver D. Howes et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses
Stefan Leucht et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation
Oliver D. Howes et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Venous Thromboembolism in Recipients of Antipsychotics
Anna K. Jönsson et al.
CNS DRUGS (2012)
Factors associated with adherence to treatment with olanzapine and other atypical antipsychotic medications in patients with schizophrenia
Hong Liu-Seifert et al.
COMPREHENSIVE PSYCHIATRY (2012)
Osteoporosis and fracture risk in people with schizophrenia
Taishiro Kishimoto et al.
CURRENT OPINION IN PSYCHIATRY (2012)
Drug-Induced Parkinsonism in the Elderly Incidence, Management and Prevention
Jose Luis Lopez-Sendon et al.
DRUGS & AGING (2012)
Clozapine resistance: Augmentation strategies
Stefano Porcelli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
The effects of guided discontinuation of antipsychotics on neurocognition in first onset psychosis
G. Faber et al.
EUROPEAN PSYCHIATRY (2012)
Eight-year trends of cardiometabolic morbidity and mortality in patients with schizophrenia
Nancy E. Morden et al.
GENERAL HOSPITAL PSYCHIATRY (2012)
Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged 65 years and over: data from a therapeutic drug monitoring service, 1996-2010
Sally Bowskill et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2012)
Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians' perceptions of adherence vs. pharmacy claims
J. J. Stephenson et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
A systematic review of the evidence of clozapine's anti-aggressive effects
Catherine Frogley et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Pharmacotherapy challenges in patients with first-episode psychosis
Amal Abdel-Baki et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Drug-Induced Parkinsonism
Hae-Won Shin et al.
JOURNAL OF CLINICAL NEUROLOGY (2012)
Overview of Violence to Self and Others During the First Episode of Psychosis
Olav B. Nielssen et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
Mark Weiser et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP
A. R. Lingford-Hughes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature
Marcia Vervloet et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2012)
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
Stefan Leucht et al.
LANCET (2012)
Teratogenic effects of antiepileptic drugs
Torbjorn Tomson et al.
LANCET NEUROLOGY (2012)
Past exposure to neuroleptic drugs and risk of Parkinson disease in an elderly cohort
Alexandra Foubert-Samier et al.
NEUROLOGY (2012)
Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial
Joo-Cheol Shim et al.
NEUROPSYCHOPHARMACOLOGY (2012)
A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia
Jose Manuel Montes et al.
PSYCHIATRY RESEARCH (2012)
Mortality in first-contact psychosis patients in the UK: a cohort study
R. Dutta et al.
PSYCHOLOGICAL MEDICINE (2012)
Association between public views of mental illness and self-stigma among individuals with mental illness in 14 European countries
S. Evans-Lacko et al.
PSYCHOLOGICAL MEDICINE (2012)
Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia
M. Lahti et al.
PSYCHOLOGICAL MEDICINE (2012)
Long-term (3-year) effectiveness of haloperidol, risperidone and olanzapine: results of a randomized, flexible-dose, open-label comparison in first-episode nonaffective psychosis
Benedicto Crespo-Facorro et al.
PSYCHOPHARMACOLOGY (2012)
Pharmacological Augmentation Strategies for Schizophrenia Patients With Insufficient Response to Clozapine: A Quantitative Literature Review
Iris E. Sommer et al.
SCHIZOPHRENIA BULLETIN (2012)
Alpha-2 receptor antagonist add-on therapy in the treatment of schizophrenia; a meta-analysis
Eric Michael Hecht et al.
SCHIZOPHRENIA RESEARCH (2012)
Symptom severity and attitudes toward medication: Impacts on adherence in outpatients with schizophrenia
Jaewon Yang et al.
SCHIZOPHRENIA RESEARCH (2012)
Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longitudinal studies
M. Alvarez-Jimenez et al.
SCHIZOPHRENIA RESEARCH (2012)
Duration of untreated psychosis and negative symptoms - A systematic review and meta-analysis of individual patient data
Nynke Boonstra et al.
SCHIZOPHRENIA RESEARCH (2012)
Prevalence and correlates of antipsychotic polypharmacy: A systematic review and meta-regression of global and regional trends from the 1970s to 2009
Juan A. Gallego et al.
SCHIZOPHRENIA RESEARCH (2012)
A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improve cognition in schizophrenia
K. N. Roy Chengappa et al.
SCHIZOPHRENIA RESEARCH (2012)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
Alkomiet Hasan et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2012)
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial
Anthony P. Morrison et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Remission in Schizophrenia: Critical and Systematic Review
Bandar AlAqeel et al.
HARVARD REVIEW OF PSYCHIATRY (2012)
A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia
Jari Tiihonen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Effects of Moderate-Dose Treatment With Varenicline on Neurobiological and Cognitive Biomarkers in Smokers and Nonsmokers With Schizophrenia or Schizoaffective Disorder
L. Elliot Hong et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Systematic Review of Early Cardiometabolic Outcomes of the First Treated Episode of Psychosis
Debra L. Foley et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Effects of an Alpha 7-Nicotinic Agonist on Default Network Activity in Schizophrenia
Jason R. Tregellas et al.
BIOLOGICAL PSYCHIATRY (2011)
Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial
Ragy R. Girgis et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
Antipsychotic Polypharmacy in Schizophrenia Benefits and Risks
Thomas R. E. Barnes et al.
CNS DRUGS (2011)
Assessing QT Interval Prolongation and its Associated Risks with Antipsychotics
Jimmi Nielsen et al.
CNS DRUGS (2011)
Pharmacological Management of Acute and Persistent Aggression in Forensic Psychiatry Settings
Leslie Citrome et al.
CNS DRUGS (2011)
Non-cardiovascular drugs that inhibit hERG-encoded potassium channels and risk of sudden cardiac death
Charlotte van Noord et al.
HEART (2011)
Relapse Prevention in First-Episode Schizophrenia-Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention: Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia
Wolfgang Gaebel et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Randomized Controlled Trial of Interventions for Young People at Ultra High Risk for Psychosis: 6-Month Analysis
Alison R. Yung et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
An Algorithm-Based Approach to First-Episode Schizophrenia: Response Rates Over 3 Prospective Antipsychotic Trials With a Retrospective Data Analysis
Ofer Agid et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Sudden Deaths in Psychiatric Patients
Peter Manu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
An International Consensus Study of Neuroleptic Malignant Syndrome Diagnostic Criteria Using the Delphi Method
Ronald J. Gurrera et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Predicting Dopamine D2 Receptor Occupancy From Plasma Levels of Antipsychotic Drugs A Systematic Review and Pooled Analysis
Hiroyuki Uchida et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
The incidence and associated risk factors for sudden unexplained death in psychiatric in-patients in England and Wales
Kirsten Windfuhr et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
Thomas R. E. Barnes
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Overlapping clusters of gray matter deficits in paranoid schizophrenia and psychotic bipolar mania with family history
Liqian Cui et al.
NEUROSCIENCE LETTERS (2011)
Suicidal Behavior and Depression in Smoking Cessation Treatments
Thomas J. Moore et al.
PLOS ONE (2011)
A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia
Gahan Pandina et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia
Huafang Li et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Views of Young People in Early Intervention Services for First-Episode Psychosis in England
Helen Lester et al.
PSYCHIATRIC SERVICES (2011)
Examining a progressive model of self-stigma and its impact on people with serious mental illness
Patrick W. Corrigan et al.
PSYCHIATRY RESEARCH (2011)
Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis
Virginia L. Stauffer et al.
PSYCHIATRY RESEARCH (2011)
Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes
Serge Sevy et al.
PSYCHIATRY RESEARCH (2011)
Remission after first-episode schizophrenia: Results of a long-term follow-up
Alp Ucok et al.
PSYCHIATRY RESEARCH (2011)
The different trajectories of antipsychotic response: antipsychotics versus placebo
T. R. Marques et al.
PSYCHOLOGICAL MEDICINE (2011)
IQ Trajectory, Cognitive Reserve, and Clinical Outcome Following a First Episode of Psychosis: A 3-Year Longitudinal Study
Verity C. Leeson et al.
SCHIZOPHRENIA BULLETIN (2011)
Low Dose vs Standard Dose of Antipsychotics for Relapse Prevention in Schizophrenia: Meta-analysis
Hiroyuki Uchida et al.
SCHIZOPHRENIA BULLETIN (2011)
The Brief Negative Symptom Scale: Psychometric Properties
Brian Kirkpatrick et al.
SCHIZOPHRENIA BULLETIN (2011)
Neurocognitive Predictors of Work Outcome in Recent-Onset Schizophrenia
Keith H. Nuechterlein et al.
SCHIZOPHRENIA BULLETIN (2011)
Pathways to Aggression in Schizophrenia Affect Results of Treatment
Jan Volavka et al.
SCHIZOPHRENIA BULLETIN (2011)
Early risk factors for suicide in an epidemiological first episode psychosis cohort
Rina Dutta et al.
SCHIZOPHRENIA RESEARCH (2011)
Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006
Uy Hoang et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
The evolution of depression and suicidality in first episode psychosis
R. Upthegrove et al.
ACTA PSYCHIATRICA SCANDINAVICA (2010)
International Consensus Study of Antipsychotic Dosing
David M. Gardner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Smoking Characteristics of Adults With Selected Lifetime Mental Illnesses: Results From the 2007 National Health Interview Survey
Annette K. McClave et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2010)
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Lawrence S. Kegeles et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders A Randomized, Placebo-Controlled Trial
G. Paul Amminger et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Reassessing the Long-term Risk of Suicide After a First Episode of Psychosis
Rina Dutta et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Treatment with antipsychotics and the risk of diabetes in clinical practice
Lars Vedel Kessing et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
Twenty-five year mortality of a community cohort with schizophrenia
Steve Brown et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
The Epidemiology of Excess Mortality in People With Mental Illness
David Lawrence et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2010)
From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics
C. U. Correll
EUROPEAN PSYCHIATRY (2010)
Death by confounding: bias and mortality
S. N. Ghaemi et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial
W. Wolfgang Fleischhacker et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Antipsychotic Polypharmacy and Risk of Death From Natural Causes in Patients With Schizophrenia: A Population-Based Nested Case-Control Study
Lone Baandrup et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
A Systematic Review of Aripiprazole-Dose, Plasma Concentration, Receptor Occupancy, and Response: Implications for Therapeutic Drug Monitoring
Anna Sparshatt et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Paliperidone Extended-Release in Schizoaffective Disorder A Randomized, Controlled Study Comparing a Flexible Dose With Placebo in Patients Treated With and Without Antidepressants and/or Mood Stabilizers
Carla M. Canuso et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
Psychiatrists' attitude towards and knowledge of clozapine treatment
J. Nielsen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia
Bruce J. Kinon et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Hyperprolactinaemia in early psychosis-not only due to antipsychotics
Jacqueline Aston et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Genetic associations of prolactin increase in olanzapine/fluoxetine combination-treated patients
John P. Houston et al.
PSYCHIATRY RESEARCH (2010)
Self-stigma and stages of change as predictors of treatment adherence of individuals with schizophrenia
Hector Wing-hong Tsang et al.
PSYCHIATRY RESEARCH (2010)
Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia
Diego Novick et al.
PSYCHIATRY RESEARCH (2010)
Weight gain in antipsychotic-naive patients: a review and meta-analysis
I. Tarricone et al.
PSYCHOLOGICAL MEDICINE (2010)
Rates of Homicide During the First Episode of Psychosis and After Treatment: A Systematic Review and Meta-analysis
Olav Nielssen et al.
SCHIZOPHRENIA BULLETIN (2010)
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
Robert W. Buchanan et al.
SCHIZOPHRENIA BULLETIN (2010)
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
Christine Rummel-Kluge et al.
SCHIZOPHRENIA RESEARCH (2010)
Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study
Marc De Hert et al.
SCHIZOPHRENIA RESEARCH (2010)
Plasma Clozapine, Norclozapine, and the Clozapine: Norclozapine Ratio in Relation to Prescribed Dose and Other Factors: Data From a Therapeutic Drug Monitoring Service, 1993-2007
Lewis Couchman et al.
THERAPEUTIC DRUG MONITORING (2010)
Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial
Eric Y. H. Chen et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Clozapine versus other atypical antipsychotics for schizophrenia
Claudia Asenjo Lobos et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Treating comorbid substance use disorders in schizophrenia
Dan I. Lubman et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2010)
Antipsychotic polypharmacy: review of mechanisms, mortality and management
Julie Langan et al.
PSYCHIATRIC BULLETIN (2010)
The therapeutic alliance: is it necessary or sufficient to engender positive outcomes?
Craig A. Macneil et al.
ACTA NEUROPSYCHIATRICA (2009)
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
Douglas E. Faries et al.
BMC PSYCHIATRY (2009)
Attitudes of patients and mental health staff to antipsychotic long-acting injections: systematic review
Linda Waddell et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies
Peter M. Haddad et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Antipsychotic long-acting injections: prescribing practice in the UK
Thomas R. E. Barnes et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Early Predictors of Nonadherence to Antipsychotic Therapy in First-Episode Psychosis
Mark Rabinovitch et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2009)
Antipsychotic Drugs for First-Episode Schizophrenia A Comparative Review
Kayvon Salimi et al.
CNS DRUGS (2009)
Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
O. D. Howes et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Pharmacotherapy of patients with schizophrenia and substance abuse
Thomas Wobrock et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence?
Leslie Citrome
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Olanzapine dosing above the licensed range is more efficacious than lower doses: fact or fiction?
Leslie Citrome et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia
John M. Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Adjunctive Aripiprazole for Schizophrenia or Schizoaffective Disorder Inadequately Treated With Quetiapine or Risperidone Monotherapy
John M. Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Depot and oral antipsychotics: patient preferences and attitudes are not the same thing
M. X. Patel et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
Jari Tiihonen et al.
LANCET (2009)
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
Shaun M. Purcell et al.
NATURE (2009)
Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
Wayne A. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Economic impact of early intervention in people at high risk of psychosis
L. R. Valmaggia et al.
PSYCHOLOGICAL MEDICINE (2009)
Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11?
A. Demjaha et al.
PSYCHOLOGICAL MEDICINE (2009)
Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials
Christoph U. Correll et al.
SCHIZOPHRENIA BULLETIN (2009)
Does the Addition of a Second Antipsychotic Drug Improve Clozapine Treatment?
Corrado Barbui et al.
SCHIZOPHRENIA BULLETIN (2009)
Psychiatric Comorbidities and Schizophrenia
Peter F. Buckley et al.
SCHIZOPHRENIA BULLETIN (2009)
Does switching to a new antipsychotic improve outcomes? Data from the CATIE Trial
Robert A. Rosenheck et al.
SCHIZOPHRENIA RESEARCH (2009)
Influence of antipsychotics on mortality in schizophrenia: Systematic review
Stefan Weinmann et al.
SCHIZOPHRENIA RESEARCH (2009)
Stigma moderates the associations of insight with depressed mood, low self-esteem, and low quality of life in patients with schizophrenia spectrum disorders
A. B. P. Staring et al.
SCHIZOPHRENIA RESEARCH (2009)
Schizophrenia and Violence: Systematic Review and Meta-Analysis
Seena Fazel et al.
PLOS MEDICINE (2009)
Clozapine-induced cardiotoxicity: a clinical update
Jamie J. Layland et al.
MEDICAL JOURNAL OF AUSTRALIA (2009)
Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia
M. Lambert et al.
ACTA PSYCHIATRICA SCANDINAVICA (2008)
Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizoaffective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study
Linmarie Sikich et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Galantamine for the treatment of cognitive impairments in people with schizophrenia
Robert W. Buchanan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
N-acetyl cysteine as a glutathione precursor for schizophrenia - A double-blind, randomized, placebo-controlled trial
Michael Berk et al.
BIOLOGICAL PSYCHIATRY (2008)
Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study
Rohan Ganguli et al.
BMC MEDICINE (2008)
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
Gunnar Morken et al.
BMC PSYCHIATRY (2008)
High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribing
Carol Paton et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Extrapyramidal side-effects of antipsychotics in a randomised trial
Del D. Miller et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: A double-blind randomized controlled trial
Lonneke J. van Nimwegen et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2008)
Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohorts
Kimford Meador et al.
EPILEPSY RESEARCH (2008)
Antipsychotic prescription patterns in outpatient settings: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study
Istvan Bitter et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
The Schizophrenia Outpatient Health Outcomes (SOHO) study: 3-year results of antipsychotic treatment discontinuation and related clinical factors in Spain
Antonio Ciudad et al.
EUROPEAN PSYCHIATRY (2008)
Overview of the findings from the European SOHO study
David Suarez et al.
Expert Review of Neurotherapeutics (2008)
Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection
Robin Emsley et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
Heterogeneity of violence in schizophrenia and implications for long-term treatment
J. Volavka et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Clozapine versus High-Dose olanzapine in refractory early-onset schizophrenia: An open-label extension study
Sanjiv Kumra et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2008)
Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: An 8-week, randomized, double-blind, placebo-controlled trial
Jae Seung Chang et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
High-dose olanzapine for treatment-resistant schizophrenia
Bryan L. Roth
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: A randomized, double-blind, flexible-dose, multicenter study
Diana O. Perkins et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
A Meta-Analysis of the Risk of Acute Extrapyramidal Symptoms With Intramuscular Antipsychotics for the Treatment of Agitation
Theodore D. Satterthwaite et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia
Herbert Y. Meltzer et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
A new look at the neonate's clinical presentation after in utero exposure to antidepressants in late pregnancy
Nina Boucher et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder - A randomized, double-blind, fixed-dose study
Bruce J. Kinon et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: Add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering
Hiroyoshi Takeuchi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder:: an open randomised clinical trial
Rene S. Kahn et al.
LANCET (2008)
Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial
H. -J. Assion et al.
PHARMACOPSYCHIATRY (2008)
Effectiveness of risperidone long-acting injection in first-episode schizophrenia: In naturalistic setting
Borah Kim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: An empirical evaluation of its reliability and predictive validity
Paul A. Nakonezny et al.
PSYCHIATRY RESEARCH (2008)
The effects of choice on intrinsic motivation and related outcomes: A meta-analysis of research findings
Erika A. Patall et al.
PSYCHOLOGICAL BULLETIN (2008)
Use of depot antipsychotic medications for medication nonadherence in schizophrenia
Joyce C. West et al.
SCHIZOPHRENIA BULLETIN (2008)
The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: Results from the CATIE study
Marvin S. Swartz et al.
SCHIZOPHRENIA RESEARCH (2008)
The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder
Matthew J. Byerly et al.
SCHIZOPHRENIA RESEARCH (2008)
Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia
Bruce J. Kinon et al.
SCHIZOPHRENIA RESEARCH (2008)
Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia
C. Daniel Mullins et al.
SCHIZOPHRENIA RESEARCH (2008)
Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study
Donald C. Goff et al.
SCHIZOPHRENIA RESEARCH (2008)
A large-scale validation study of the medication adherence rating scale (MARS)
Laura Fialko et al.
SCHIZOPHRENIA RESEARCH (2008)
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Julia Hippisley-Cox et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
A systematic review of the Soteria paradigm for the treatment of people diagnosed with schizophrenia
Tim Calton et al.
SCHIZOPHRENIA BULLETIN (2008)
Cessation of medication for people with schizophrenia already stable on chlorpromazine
Muhammad Qutayba Almerie et al.
SCHIZOPHRENIA BULLETIN (2008)
Aripiprazole in the treatment of the psychosis prodrome
Scott W. Woods et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone? - A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting
Takefumi Suzuki et al.
PSYCHOPHARMACOLOGY (2007)
Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis
S. Ruhrmann et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study
Dan Zimbroff et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2007)
Treatment of schizophrenia with long-acting fluphenazine, haloperidol, or risperidone
Mark Olfson et al.
SCHIZOPHRENIA BULLETIN (2007)
Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostility
Leslie Citrome et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2007)
A systematic review of mortality in schizophrenia - Is the differential mortality gap worsening over time?
Sukanta Saha et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: A randomized, open-label, controlled trial
Sung-Wan Kim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia - Is it a practice effect?
Terry E. Goldberg et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
The Cognitive and Negative Symptoms in Schizophrenia, Trial (CONSIST): The efficacy of glutamatergic agents for negative symptoms and cognitive impairments
Robert W. Buchanan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration
Babur Yusufi et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2007)
Shared decision making and long-term outcome in schizophrenia treatment
Johannes Hamann et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
A preclinical and clinical rationale for quetiapine in mood syndromes
Roger S. McIntyre et al.
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Increased mortality among patients admitted with major psychiatric disorders: A register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia
Thomas Munk Laursen et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial
Richard S. E. Keefe et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Is ciozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia?
Kanapathippillai Karunakaran et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Declining transition rate in ultra high risk (prodromal) services: Dilution or reduction of risk?
Alison R. Yung et al.
SCHIZOPHRENIA BULLETIN (2007)
Guide discontinuaton vesus maintenance treatment in remitted first-episode psychosis: Relapse rates and functional outcome
Lex Wunderink et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Risperidone augmentation for schizophrenia partially responsive to clozapine: A double-blind, placebo-controlled trial
Oliver Freudenreich et al.
SCHIZOPHRENIA RESEARCH (2007)
Overlooking the obvious - A meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia
Dwight Dickinson et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Augmentation with a second antipsychotic in patients with schizophrenia who partially respond to clozapine - A meta-analysis
Carol Paton et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents
Barbara A. Cornblatt et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Financial incentives for antipsychotic depot medication: ethical issues
Dirk Claassen
JOURNAL OF MEDICAL ETHICS (2007)
Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations
Bengt A. J. Kallen et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2007)
A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics, for the cognitive impairments in chronic schizophrenia
Sae-Woom Lee et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2007)
Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database
David P. J. Osborn et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
The burden of depressive symptoms in the long-term treatment of patients with schizophrenia
Robert R. Conley et al.
SCHIZOPHRENIA RESEARCH (2007)
Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis
Carol L. M. Caton et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Monitoring the safe use of clozapine - A consensus view from Victoria, Australia
Michael Berk et al.
CNS DRUGS (2007)
Antipsychotic medication adherence in schizophrenia
Matthew J. Byerly et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2007)
Adverse effects of atypical antipsychotics: Differential risk and clinical implications
Peter M. Haddad et al.
CNS DRUGS (2007)
Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: A single-blind randomized study
Yasin Genc et al.
ADVANCES IN THERAPY (2007)
Attitudes of psychiatrists toward antipsychotic depot medication
Stephan Heres et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Adherence therapy for people with schizophrenia - European multicentre randomised controlled trial
Richard Gray et al.
BRITISH JOURNAL OF PSYCHIATRY (2006)
Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: A retrospective database study
Alexandra Ward et al.
CLINICAL THERAPEUTICS (2006)
Predicting medication-free treatment response in acute psychosis -: Cross-validation from the Finnish need-adopted project
John Robert Bola et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2006)
Neurocognitive performance and negative symptoms: Are they equal in explaining disability in schizophrenia outpatients?
Victoria Villalta-Gil et al.
SCHIZOPHRENIA RESEARCH (2006)
Antipsychotic adherence over time among patients receiving treatment for schizophrenia: A retrospective review
Marcia Valenstein et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Psychotic spectrum disorders and alcohol abuse: A review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram
Ismene L. Petrakis et al.
SCHIZOPHRENIA BULLETIN (2006)
Linking the PANSS, BPRS, and CGI: Clinical implications
Stefan Leucht et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia
Shon W. Lewis et al.
SCHIZOPHRENIA BULLETIN (2006)
Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia - Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)
Peter B. Jones et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Galantamine improves cognition in schizophrenic patients stabilized on risperidone
Max H. Schubert et al.
BIOLOGICAL PSYCHIATRY (2006)
Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors:: Comparing aripiprazole to other antipsychotics in animal models
Sridhar Natesan et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: An empirical evaluation of olanzapine, risperidone, and quetiapine
Matthew J. Byerly et al.
SCHIZOPHRENIA RESEARCH (2006)
The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study
Chanoch Miodownik et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Aripiprazole for schizophrenia - Systematic review
H. G. El-Sayeh et al.
BRITISH JOURNAL OF PSYCHIATRY (2006)
Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder:: observational follow-up study
Jari Tiihonen et al.
BRITISH MEDICAL JOURNAL (2006)
Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder
Menahem I. Krakowski et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Psychotic-like experiences in nonpsychotic help-seekers: Associations with distress, depression, and disability
AR Yung et al.
SCHIZOPHRENIA BULLETIN (2006)
Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring
PFJ Schulte
ANNALS OF PHARMACOTHERAPY (2006)
The NIMH-MATRICS consensus statement on negative symptoms
B Kirkpatrick et al.
SCHIZOPHRENIA BULLETIN (2006)
Negative symptoms and cognitive deficits: What is the nature of their relationship?
PD Harvey et al.
SCHIZOPHRENIA BULLETIN (2006)
Suicide behaviour over 18 months in recent onset schizophrenic patients: The effects of CBT
N Tarrier et al.
SCHIZOPHRENIA RESEARCH (2006)
Substance use in persons with schizophrenia - Baseline prevalence and correlates from the NIMH CATIE study
MS Swartz et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2006)
Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care
H Ascher-Svanum et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Clozapine alone versus clozapine and risperidone with refractory schizophrenia
WG Honer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A prospective evaluation of adherence to medication in first episode schizophrenia
M Kamali et al.
EUROPEAN PSYCHIATRY (2006)
Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence
C Arango et al.
EUROPEAN PSYCHIATRY (2006)
Schizophrenia and increased risks of cardiovascular disease
CH Hennekens et al.
AMERICAN HEART JOURNAL (2005)
Early warning signs of relapse following a first episode of psychosis
JF Gleeson et al.
SCHIZOPHRENIA RESEARCH (2005)
Diagnostic stability 18 months after treatment initiation for first-episode psychosis
BG Schimmelmann et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Management of agitation, aggression, and psychosis associated with dementia: A pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone
PP De Deyn et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2005)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Schizophrenia and depression:: Challenging the paradigm of two separate diseases -: A controlled study of schizophrenia, depression and healthy controls
H Häfner et al.
SCHIZOPHRENIA RESEARCH (2005)
Schizophrenia practice guidelines: international survey and comparison
W Gaebel et al.
BRITISH JOURNAL OF PSYCHIATRY (2005)
A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder
MJ Byerly et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state
MR Broome et al.
EUROPEAN PSYCHIATRY (2005)
Randomized controlled augmentation trials in clozapine-resistant schizophrenic patients: a critical review
VP Kontaxakis et al.
EUROPEAN PSYCHIATRY (2005)
The crossover approach to switching antipsychotics: What is the evidence?
G Remington et al.
SCHIZOPHRENIA RESEARCH (2005)
A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors
J de Leon et al.
SCHIZOPHRENIA RESEARCH (2005)
Attitudes toward antipsychotic medication - The impact of clinical variables and relationships with health professionals
JC Day et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Early-onset hypothesis of antipsychotic drug action: A hypothesis tested, confirmed and extended
S Leucht et al.
BIOLOGICAL PSYCHIATRY (2005)
Psychological pathways to depression in schizophrenia - Studies in acute psychosis, post psychotic depression and auditory hallucinations
M Birchwood et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2005)
Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders
BJ Kinon et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Does clozapine decrease smoking?
J de Leon et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Risperidone and haloperidol in first-episode psychosis: A long-term randomized trial
N Schooler et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics - data on a previously published randomised controlled trial
S Rathod et al.
SCHIZOPHRENIA RESEARCH (2005)
Suicide risk in relation to psychiatric hospitalization - Evidence based on longitudinal registers
P Qin et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Antidepressive effects of traditional and second generation antipsychotics:: a review of the clinical data
HJ Möller
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2005)
The lifetime risk of suicide in schizophrenia - A reexamination
BA Palmer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: A longitudinal first-episode study with 7-year follow-up
P Milev et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Remission in schizophrenia: Proposed criteria and rationale for consensus
NC Andreasen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Prodromal interventions for schizophrenia vulnerability: the risks of being at risk
C Corcoran et al.
SCHIZOPHRENIA RESEARCH (2005)
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
ND Woodward et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Combination of clozapine and ziprasidone in treatment-resistant schizophrenia - An open clinical study
M Ziegenbein et al.
CLINICAL NEUROPHARMACOLOGY (2005)
Association between duration of untreated psychosis and in cohorts of first-episode outcome patients - A systematic review
M Marshall et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety
AEA Yagcioglu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Clozapine augmented with risperidone in the treatment of schizophrenia: A randomized, double-blind, placebo-controlled trial
RC Josiassen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Patterns of concomitant psychotropic medication use during a 2-year study comparing clozapine and olanzapine for the prevention of suicidal behavior
ID Glick et al.
JOURNAL OF CLINICAL PSYCHIATRY (2004)
Dose response and dose equivalence of antipsychotics
JM Davis et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Multiple versus single antipsychotic agents for hospitalized psychiatric patients: Case-control study of risks versus benefits
F Centorrino et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Cognitive-behavioural therapy in first-episode and early schizophrenia - 18-month follow-up of a randomised controlled trial
N Tarrier et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: A predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients
A Rostami-Hodjegan et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Partial compliance and risk of rehospitalization among California medicaid patients with schizophrenia
PJ Weiden et al.
PSYCHIATRIC SERVICES (2004)
Brief evaluation of medication influences and beliefs - Development and testing of a brief scale for medication adherence
CR Dolder et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Antipsychotic-induced hyperprolactinaemia: Mechanisms, clinical features and management
PM Haddad et al.
DRUGS (2004)
Antipsychotics and the risk of sudden cardiac death
SMJM Straus et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Adapting to the challenge of psychosis: personal resilience and the use of sealing-over (avoidant) coping strategies
L Tait et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
Non-adherence to antipsychotic medication regimens: associations with resource use and costs
M Knapp et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
Cognitive therapy for the prevention of psychosis in people at ultra-high risk - Randomised controlled trial
AP Morrison et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
Ethical use of long-acting medications in the treatment of severe and persistent mental illnesses
LW Roberts et al.
COMPREHENSIVE PSYCHIATRY (2004)
Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia
I Bitter et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Delayed-onset hypothesis of antipsychotic action - A hypothesis tested and rejected
O Agid et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Compliance therapy: a randomised controlled trial in schizophrenia
C O'Donnell et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Depression and subjective quality of life in chronic phase schizophrenic patients
G Reine et al.
ACTA PSYCHIATRICA SCANDINAVICA (2003)
Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome
SW Woods et al.
BIOLOGICAL PSYCHIATRY (2003)
Recovery style and outcome in first-episode psychosis
KN Thompson et al.
SCHIZOPHRENIA RESEARCH (2003)
Relapse prevention in schizophrenia with new-generation antipsychotics: A systematic review and exploratory meta-analysis of randomized, controlled trials
S Leucht et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Increased suicide attempt rate among patients interrupting use of atypical antipsychotics
RMC Herings et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2003)
Comparability of whole-blood and plasma clozapine and norclozapine concentrations
RJ Flanagan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Differential effect of quetiapine on depressive symptoms in patients with partially responsive schizophrenia
RA Emsley et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2003)
Antidepressants for the treatment of depression in people with schizophrenia: a systematic review
C Whitehead et al.
PSYCHOLOGICAL MEDICINE (2003)
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis I. Study rationale and design
TH McGlashan et al.
SCHIZOPHRENIA RESEARCH (2003)
Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia:: A 52-week randomized trial of clozapine vs chlorpromazine
JA Lieberman et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Diet, smoking and cardiovascular risk in people with schizophrenia - Descriptive study
RG McCreadie
BRITISH JOURNAL OF PSYCHIATRY (2003)
Induced QT prolongation and torsades de pointes
YG Yap et al.
HEART (2003)
What is an adequate trial with clozapine? Therapeutic drug monitoring and time to response in treatment-refractory schizophrenia
PFJ Schulte
CLINICAL PHARMACOKINETICS (2003)
Analysis of healthcare utilization patterns and adherence in patients receiving typical and atypical antipsychotic medications
IS Al-Zakwani et al.
CURRENT MEDICAL RESEARCH AND OPINION (2003)
Does treatment delay in first-episode psychosis really matter?
SM Harrigan et al.
PSYCHOLOGICAL MEDICINE (2003)
Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms
PD McGorry et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: An open-label switch study
JP Lindenmayer et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature
JP Lacro et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Medication adherence of individuals with a first episode of psychosis
EL Coldham et al.
ACTA PSYCHIATRICA SCANDINAVICA (2002)
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder
RM Bilder et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Thioridazine and sudden unexplained death in psychiatric in-patients
JG Reilly et al.
BRITISH JOURNAL OF PSYCHIATRY (2002)
Precipitation and determination of the onset and course of schizophrenia by substance abuse -: a retrospective and prospective study of 232 population-based first illness episodes
B Bühler et al.
SCHIZOPHRENIA RESEARCH (2002)
A multidose study of haloperidol decanoate in the maintenance treatment of schizophrenia
JM Kane et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse
GE Hunt et al.
SCHIZOPHRENIA RESEARCH (2002)
Toxic interaction between risperidone and clozapine: A case report
VP Kontaxakis et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)
Antipsychotic medication adherence: Is there a difference between typical and atypical agents?
CR Dolder et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Relapse and rehospitalisation rates in patients with schizophrenia - Effects of second generation antipsychotics
JG Csernansky et al.
CNS DRUGS (2002)
Injections of depot antipsychotic medications in patients suffering from schizophrenia: Do they hurt?
Y Bloch et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia
M Gitlin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia
L Citrome et al.
PSYCHIATRIC SERVICES (2001)
Risks for individuals with schizophrenia who are living in the community
JS Brekke et al.
PSYCHIATRIC SERVICES (2001)
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: A review and meta-analysis of randomized trials
M Chakos et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
A cognitive model of the positive symptoms of psychosis
PA Garety et al.
PSYCHOLOGICAL MEDICINE (2001)
Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine
GD Tollefson et al.
BIOLOGICAL PSYCHIATRY (2001)
Cognitive approach to depression and suicidal thinking in psychosis 2. Testing the validity of a social ranking model
Z Iqbal et al.
BRITISH JOURNAL OF PSYCHIATRY (2000)
Causes and consequences of duration of untreated psychosis in schizophrenia
RJ Drake et al.
BRITISH JOURNAL OF PSYCHIATRY (2000)
Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans:: a clinical PET study
S Silvestri et al.
PSYCHOPHARMACOLOGY (2000)
Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients
M Dettling et al.
PSYCHOPHARMACOLOGY (2000)
Cardiovascular adverse effects of antipsychotic drugs
NA Buckley et al.
DRUG SAFETY (2000)
Two-year outcome in first-episode psychosis treated according to an integrated model.: Is immediate neuroleptisation always needed?
V Lehtinen et al.
EUROPEAN PSYCHIATRY (2000)
Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis
JE Schwartz et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
What is the clinical significance of the discontinuation syndrome seen with clozapine?
AJ Goudie
JOURNAL OF PSYCHOPHARMACOLOGY (2000)
Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses
K Thompson et al.
SCHIZOPHRENIA RESEARCH (2000)
Medication continuation and compliance: A comparison of patients treated with clozapine and haloperidol
R Rosenheck et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)
Relationship between dopamine D2 occupancy, clinical response, and side effects:: A double-blind PET study of first-episode schizophrenia
S Kapur et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Effect of clozapine on polypharmacy
SA Chong et al.
PSYCHIATRIC SERVICES (2000)
Use of sodium valproate in violent and aggressive behaviors: A critical review
JP Lindenmayer et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)
Depression in schizophrenia: Perspective in the era of atypical antipsychotic agents
SG Siris
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Share Paper
